ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of the Role of Nocturnal Non-Invasive Ventilation in Pulmonary Rehabilitation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00710463
Recruitment Status : Completed
First Posted : July 4, 2008
Last Update Posted : July 4, 2008
Sponsor:
Collaborator:
Hannover Medical School
Information provided by:
Deutsche Lungenstiftung e.V.

Brief Summary:

Hypothesis: Hospital based, comprehensive pulmonary rehabilitation of patients with COPD in GOLD stage IV can be optimized by application of nocturnal non invasive ventilation.

This hypotheses shall be tested by an observational trial, comparing rehabilitation effects of a prospectively observed group receiving non invasive ventilation, compared wiht a historical control group of patients who did received the same treatment without non invasive ventilation.


Condition or disease Intervention/treatment
Pulmonary Disease, Chronic Obstructive Device: non invasive ventilation (Resmed VPAP III ST-A, Respironics Harmony)

Detailed Description:

Non invasive ventilation is known to allow improvements if applied during endurance training, but this is technically difficult. Nocturnal application of non invasive ventilation is known to unload the ventilatory pump, reset the control of breathing, and improve sleep quality.

The protocol also aimed to evaluate the acceptance of non invasive ventilation in patients undergoing a four week inpatient pulmonary rehabilitation programme.


Study Type : Observational
Actual Enrollment : 80 participants
Observational Model: Cohort
Official Title: Evaluation of the Role of Nocturnal Non-Invasive Ventilation in Pulmonary Rehabilitation
Study Start Date : May 2003
Actual Primary Completion Date : September 2007
Actual Study Completion Date : November 2007

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Rehabilitation
U.S. FDA Resources

Group/Cohort Intervention/treatment
Control group
patients receive a hospital based comprehensive pulmonary rehabilitation programme, including endurance training, physiotherapy, medical therapy, and long term oxygen treatment when indicated.
NIV treatment group
patients receive a hospital based comprehensive pulmonary rehabilitation programme, including endurance training, physiotherapy, medical therapy, and long term oxygen treatment when indicated, plus newly introduced nocturnal non invasive ventilation.
Device: non invasive ventilation (Resmed VPAP III ST-A, Respironics Harmony)
non invasive ventilation was performed with commercially available ventilators from the manufacturers Resmed and Respironics.
Other Names:
  • Resmed VPAP III ST-A
  • Respironics Harmony



Primary Outcome Measures :
  1. six minute walk distance [ Time Frame: beginning to end of rehabilitation ]

Secondary Outcome Measures :
  1. quality of life [ Time Frame: beginning to end of rehabilitation ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

All patients were recruited at a single center, the rehabilitation hospital "Klinikum Berchtesgadener Land" at Germany.

Patients entering the well defined, hospital based pulmonary rehabilitation programme after Januar 1, 2005 were additionally treated with nocturnal non invasive ventilation. The results of these patients were compared with a group of patients who underwent the same rehabilitation programme in the years 2003 to 2005, when non invasive ventilation was not availabe.

Criteria

Inclusion Criteria:

  • Confirmed diagnosis of COPD in stages GOLD IV
  • Receiving optimized medical treatment and long term oxygen treatment, if indicated
  • Patient's consent to participate in this trial

Exclusion Criteria:

  • Previous treatment with NIPPV
  • Unwillingness or intolerance to perform NIPPV
  • Acute exacerbation of COPD at baseline or during pulmonary rehabilitation,
  • Significant orthopaedic or neurologic problems that reduce mobility or cooperation with physical training
  • Poor controlled coexisting psychiatric or unstable cardiac disease,
  • Inability to perform a six minute walk test
  • Extreme hypercapnia (pCO2 > 74 mmHg)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00710463


Locations
Germany
Klinikum Berchtesgadener Land
Berchtesgaden, Germany, D-83471
Sponsors and Collaborators
Deutsche Lungenstiftung e.V.
Hannover Medical School
Investigators
Study Director: Klaus Kenn, MD Klinikum Berchtesgadener Land
Principal Investigator: Ursula Schönheit-Kenn, ME Klinikum Berchtesgadener Land

Responsible Party: Dr. Klaus Kenn, Klinikum Berchtesgadener Land, Malterhöh 1, D-83471 Berchtesgaden
ClinicalTrials.gov Identifier: NCT00710463     History of Changes
Other Study ID Numbers: NIV and Rehabilitation
First Posted: July 4, 2008    Key Record Dates
Last Update Posted: July 4, 2008
Last Verified: July 2008

Keywords provided by Deutsche Lungenstiftung e.V.:
COPD
non invasive ventilation
pulmonary rehabilitation

Additional relevant MeSH terms:
Lung Diseases
Chronic Disease
Pulmonary Disease, Chronic Obstructive
Respiratory Tract Diseases
Disease Attributes
Pathologic Processes
Lung Diseases, Obstructive